A Study of the Effects of Co-Administration of Sitagliptin (MK-0431) and Metformin on Incretin Hormone Concentrations (MK-0431-110)

NCT00830076 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: sitagliptin phosphate
DRUG: metformin hydrochloride
DRUG: Comparator: placebo sitagliptin
DRUG: Comparator: placebo metformin

Sponsor

Merck Sharp & Dohme LLC